Trials / Completed
CompletedNCT06654960
Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects
A Single Center, Open-label, Single Cohort, Fixed Sequence Trial, Investigating the Influence of HRS9531 Injection on Pharmacokinetics of Metformin in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the influence of HRS9531 injection on pharmacokinetics of metformin in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS9531 injection | HRS9531 injection single dose. |
| DRUG | Metformin Hydrochloride tablets | Metformin Hydrochloride tablets 500mg. |
Timeline
- Start date
- 2024-11-05
- Primary completion
- 2024-12-26
- Completion
- 2024-12-26
- First posted
- 2024-10-23
- Last updated
- 2025-01-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06654960. Inclusion in this directory is not an endorsement.